Brokerages predict that ICU Medical, Incorporated (NASDAQ:ICUI) will announce $1.62 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for ICU Medical’s earnings. The lowest EPS estimate is $1.57 and the highest is $1.66. ICU Medical reported earnings per share of $2.07 in the same quarter last year, which would indicate a negative year over year growth rate of 21.7%. The company is scheduled to announce its next earnings report on Thursday, February 27th.
On average, analysts expect that ICU Medical will report full year earnings of $7.85 per share for the current year, with EPS estimates ranging from $7.80 to $7.89. For the next fiscal year, analysts forecast that the business will post earnings of $6.88 per share, with EPS estimates ranging from $6.65 to $7.10. Zacks’ earnings per share averages are a mean average based on a survey of research firms that that provide coverage for ICU Medical.
ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Monday, November 11th. The medical instruments supplier reported $1.65 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.62 by $0.03. The business had revenue of $307.47 million during the quarter, compared to the consensus estimate of $297.83 million. ICU Medical had a net margin of 5.66% and a return on equity of 12.13%. The business’s revenue for the quarter was down 6.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.85 earnings per share.
In other news, Director Robert S. Swinney sold 373 shares of the stock in a transaction on Monday, October 14th. The shares were sold at an average price of $153.49, for a total value of $57,251.77. Following the sale, the director now owns 18,845 shares in the company, valued at $2,892,519.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director George A. Lopez sold 20,000 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $184.29, for a total transaction of $3,685,800.00. Following the completion of the sale, the director now owns 368,864 shares in the company, valued at approximately $67,977,946.56. The disclosure for this sale can be found here. Insiders own 11.40% of the company’s stock.
A number of large investors have recently bought and sold shares of ICUI. Advisory Services Network LLC raised its stake in shares of ICU Medical by 70.2% during the 2nd quarter. Advisory Services Network LLC now owns 143 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 59 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in shares of ICU Medical by 1,389.5% in the third quarter. Quadrant Capital Group LLC now owns 283 shares of the medical instruments supplier’s stock worth $43,000 after buying an additional 264 shares during the last quarter. Quest Capital Management Inc. ADV acquired a new stake in ICU Medical during the third quarter worth about $80,000. Huntington National Bank grew its holdings in ICU Medical by 17.9% during the third quarter. Huntington National Bank now owns 559 shares of the medical instruments supplier’s stock worth $89,000 after acquiring an additional 85 shares during the period. Finally, DRW Securities LLC purchased a new position in ICU Medical during the second quarter valued at approximately $204,000. 91.85% of the stock is currently owned by institutional investors.
Shares of ICUI stock opened at $185.24 on Thursday. The firm has a market capitalization of $3.83 billion, a price-to-earnings ratio of 24.03 and a beta of 0.92. The business has a fifty day moving average of $172.59 and a 200 day moving average of $196.36. ICU Medical has a 1 year low of $148.89 and a 1 year high of $259.72.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.